Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.000
+0.005 (0.47%)
Apr 1, 2026, 1:48 PM EDT - Market open

Actinium Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
314239140273133
Market Cap Growth
-18.76%7.94%-72.00%-48.66%105.46%-2.69%
Enterprise Value
-15.25-4.6-32.665.28166.6155.26
Last Close Price
1.001.361.265.0810.656.01
PE Ratio
--1.25-0.99-2.78-7.77-5.01
PS Ratio
344.99471.40-1733.11265.47116.33
PB Ratio
3.965.421.203.864.111.81
P/TBV Ratio
3.985.421.163.723.871.68
P/FCF Ratio
--1.72-1.19-2.9633.03-6.34
P/OCF Ratio
--1.73-1.19-2.9731.63-6.38
EV/Sales Ratio
--51.11-805.89161.7648.30
EV/EBITDA Ratio
-0.130.78-1.26-4.99-2.26
EV/EBIT Ratio
-0.130.77-1.26-4.89-2.21
EV/FCF Ratio
-0.190.99-1.3720.13-2.63
Debt / Equity Ratio
0.120.120.030.040.030.00
Debt / EBITDA Ratio
-0.05-0.05-0.04-0.04-0.08-0.01
Debt / FCF Ratio
-0.07-0.07-0.05-0.040.31-0.01
Net Debt / Equity Ratio
-5.91-5.91-2.18-2.05-1.60-1.05
Net Debt / EBITDA Ratio
1.281.281.701.443.183.17
Net Debt / FCF Ratio
1.881.882.161.57-12.843.69
Asset Turnover
0.000.0000.000.010.02
Quick Ratio
6.026.028.959.0310.2511.38
Current Ratio
6.026.028.959.2110.4411.66
Return on Equity (ROE)
-166.96%-166.96%-110.63%-94.92%-47.16%-36.74%
Return on Assets (ROA)
-56.34%-56.34%-53.20%-53.08%-35.05%-34.01%
Return on Invested Capital (ROIC)
1029.31%1029.31%1246.55%1292.67%871.78%1114.71%
Return on Capital Employed (ROCE)
-64.41%-64.41%-59.45%-58.83%-38.51%-36.94%
Earnings Yield
-109.14%-80.15%-100.79%-36.02%-12.86%-19.97%
FCF Yield
-79.50%-58.18%-84.17%-33.83%3.03%-15.78%
Buyback Yield / Dilution
-3.74%-3.74%-13.03%-10.20%-17.37%-69.51%
Total Shareholder Return
-3.74%-3.74%-13.03%-10.20%-17.37%-69.51%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q